Drug Shortage Report for IRBESARTAN HCT

Last updated on 2019-05-06 History
Report ID 80252
Drug Identification Number 02385317
Brand name IRBESARTAN HCT
Common or Proper name IRBESARTAN
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-04-15
Actual start date 2019-04-05
Estimated end date 2019-05-01
Actual end date 2019-05-02
Shortage status Resolved
Updated date 2019-05-06
Company comments
Health Canada comments
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-05-06 French Compare
v9 2019-05-06 English Compare
v8 2019-04-30 French Compare
v7 2019-04-30 English Compare
v6 2019-04-29 French Compare
v5 2019-04-29 English Compare
v4 2019-04-09 French Compare
v3 2019-04-09 English Compare
v2 2019-04-01 French Compare
v1 2019-04-01 English Compare